Neonatal and infant immunity for tuberculosis vaccine development: importance of age-matched animal models

Neonatal and infant immunity differs from that of adults in both the innate and adaptive arms, which are critical contributors to immune-mediated clearance of infection and memory responses elicited during vaccination. The tuberculosis (TB) research community has openly admitted to a vacuum of knowl...

Full description

Bibliographic Details
Main Authors: Laylaa Ramos, Joan K. Lunney, Mercedes Gonzalez-Juarrero
Format: Article
Language:English
Published: The Company of Biologists 2020-09-01
Series:Disease Models & Mechanisms
Subjects:
Online Access:http://dmm.biologists.org/content/13/9/dmm045740
id doaj-45bf6bf0cf5244ad88c49ebf510c575f
record_format Article
spelling doaj-45bf6bf0cf5244ad88c49ebf510c575f2020-11-25T03:50:45ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112020-09-0113910.1242/dmm.045740045740Neonatal and infant immunity for tuberculosis vaccine development: importance of age-matched animal modelsLaylaa Ramos0Joan K. Lunney1Mercedes Gonzalez-Juarrero2 Mycobacteria Research Laboratories, Microbiology Immunology and Pathology Department, Colorado State University, 1682 Campus Delivery, Fort Collins, CO 80523, USA Animal Parasitic Diseases Laboratory, BARC, NEA, ARS, USDA Building 1040, Room 103, Beltsville, MD 20705, USA Mycobacteria Research Laboratories, Microbiology Immunology and Pathology Department, Colorado State University, 1682 Campus Delivery, Fort Collins, CO 80523, USA Neonatal and infant immunity differs from that of adults in both the innate and adaptive arms, which are critical contributors to immune-mediated clearance of infection and memory responses elicited during vaccination. The tuberculosis (TB) research community has openly admitted to a vacuum of knowledge about neonatal and infant immune responses to Mycobacterium tuberculosis (Mtb) infection, especially in the functional and phenotypic attributes of memory T cell responses elicited by the only available vaccine for TB, the Bacillus Calmette–Guérin (BCG) vaccine. Although BCG vaccination has variable efficacy in preventing pulmonary TB during adolescence and adulthood, 80% of endemic TB countries still administer BCG at birth because it has a good safety profile and protects children from severe forms of TB. As such, new vaccines must work in conjunction with BCG at birth and, thus, it is essential to understand how BCG shapes the immune system during the first months of life. However, many aspects of the neonatal and infant immune response elicited by vaccination with BCG remain unknown, as only a handful of studies have followed BCG responses in infants. Furthermore, most animal models currently used to study TB vaccine candidates rely on adult-aged animals. This presents unique challenges when transitioning to human trials in neonates or infants. In this Review, we focus on vaccine development in the field of TB and compare the relative utility of animal models used thus far to study neonatal and infant immunity. We encourage the development of neonatal animal models for TB, especially the use of pigs.http://dmm.biologists.org/content/13/9/dmm045740immunityneonataltuberculosisvaccines
collection DOAJ
language English
format Article
sources DOAJ
author Laylaa Ramos
Joan K. Lunney
Mercedes Gonzalez-Juarrero
spellingShingle Laylaa Ramos
Joan K. Lunney
Mercedes Gonzalez-Juarrero
Neonatal and infant immunity for tuberculosis vaccine development: importance of age-matched animal models
Disease Models & Mechanisms
immunity
neonatal
tuberculosis
vaccines
author_facet Laylaa Ramos
Joan K. Lunney
Mercedes Gonzalez-Juarrero
author_sort Laylaa Ramos
title Neonatal and infant immunity for tuberculosis vaccine development: importance of age-matched animal models
title_short Neonatal and infant immunity for tuberculosis vaccine development: importance of age-matched animal models
title_full Neonatal and infant immunity for tuberculosis vaccine development: importance of age-matched animal models
title_fullStr Neonatal and infant immunity for tuberculosis vaccine development: importance of age-matched animal models
title_full_unstemmed Neonatal and infant immunity for tuberculosis vaccine development: importance of age-matched animal models
title_sort neonatal and infant immunity for tuberculosis vaccine development: importance of age-matched animal models
publisher The Company of Biologists
series Disease Models & Mechanisms
issn 1754-8403
1754-8411
publishDate 2020-09-01
description Neonatal and infant immunity differs from that of adults in both the innate and adaptive arms, which are critical contributors to immune-mediated clearance of infection and memory responses elicited during vaccination. The tuberculosis (TB) research community has openly admitted to a vacuum of knowledge about neonatal and infant immune responses to Mycobacterium tuberculosis (Mtb) infection, especially in the functional and phenotypic attributes of memory T cell responses elicited by the only available vaccine for TB, the Bacillus Calmette–Guérin (BCG) vaccine. Although BCG vaccination has variable efficacy in preventing pulmonary TB during adolescence and adulthood, 80% of endemic TB countries still administer BCG at birth because it has a good safety profile and protects children from severe forms of TB. As such, new vaccines must work in conjunction with BCG at birth and, thus, it is essential to understand how BCG shapes the immune system during the first months of life. However, many aspects of the neonatal and infant immune response elicited by vaccination with BCG remain unknown, as only a handful of studies have followed BCG responses in infants. Furthermore, most animal models currently used to study TB vaccine candidates rely on adult-aged animals. This presents unique challenges when transitioning to human trials in neonates or infants. In this Review, we focus on vaccine development in the field of TB and compare the relative utility of animal models used thus far to study neonatal and infant immunity. We encourage the development of neonatal animal models for TB, especially the use of pigs.
topic immunity
neonatal
tuberculosis
vaccines
url http://dmm.biologists.org/content/13/9/dmm045740
work_keys_str_mv AT laylaaramos neonatalandinfantimmunityfortuberculosisvaccinedevelopmentimportanceofagematchedanimalmodels
AT joanklunney neonatalandinfantimmunityfortuberculosisvaccinedevelopmentimportanceofagematchedanimalmodels
AT mercedesgonzalezjuarrero neonatalandinfantimmunityfortuberculosisvaccinedevelopmentimportanceofagematchedanimalmodels
_version_ 1724490771272302592